To amend the Public Health Service Act to reauthorize certain poison control programs.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend the Public Health Service Act to reauthorize certain poison control programs., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Immigration.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H0BD1AC53604346778CC1B4C9F8E4DA73: 1. Short title This Act may be cited as the Poison Control Centers Reauthorization Act of 2024.
- Section HBAE47D94B87C4908B70C502417CE48EC: 2. Reauthorization of poison control programs Section 1271(c) of the Public Health Service Act (42 U.S.C. 300d–71(c)) is amended by striking fiscal years 2020...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend the Public Health Service Act to reauthorize certain poison control programs., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Immigration
Primary Purpose
This bill, To amend the Public Health Service Act to reauthorize certain poison control programs., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
ReportedAdditional sponsors: Mr. Carter of Georgia, Mr. Tonko, Mr. Bacon, …
Reported with an amendment, committed to the Committee of the …
Mrs. Chavez-DeRemer (for herself, Mr. Joyce of Pennsylvania, Mr. Davis …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology